Clinical trial
Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the…
NCT00003864 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003864 |
|---|---|
| Title | Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus |
| Official title | A Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, docetaxel |
| Start date | Sep 3, 1999 |
| Primary completion | Jan 1, 2004 |
| First posted | Apr 2, 2004 |
| Last update posted | Jun 15, 2023 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: